Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anus Neoplasms × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Thyroid Neoplasms 1 Psoriasis Vulgaris 1 Pelvic Neoplasms 1 Mucositis 1 Malnutrition 1 Infections 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Enteritis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Therapy-related Cardiovascular Toxicity 1 Anus Neoplasms 1 Adenomatous Polyposis Coli 1

Interventions

Fluorouracil 4 Paclitaxel 3 Mitomycin 3 Capecitabine 3 Radiotherapy 2 Radiation 2 Cisplatin 2 Carboplatin 2 fludarabine 1 dehydroftorafur 1 avelumab 1 Taxes 1 Ritonavir 1 Probiotics 1 Prebiotics 1 Platinum 1 Oxaliplatin 1 Mitomycins 1 Interleukin-2 1 Indinavir 1 Immune Checkpoint Inhibitors 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Diathermy 1 Cyclophosphamide 1 Chemoradiotherapy 1 Cetuximab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡